New blood thinner tested for rare clotting disorder

This study looked at how well the drug argatroban works in 20 adults with a condition called heparin-induced thrombocytopenia Type II, where the blood thinner heparin causes low platelets and raises clot risk. Participants received argatroban to prevent new or worsening blood clots. Researchers tracked deaths, new clots, amputations, and bleeding to understand the drug's safety and effectiveness.